TSX.V:TIG OTCMKTS: TIGCF Frankfurt: 8N61 VANCOUVER, Jan. 22, 2018 /CNW/ - Triumph Gold Corp., (TSX-V: TIG) (OTCMKTS: NFRGF) ("Triumph Gold" or the "Company") is pleased to announce the results of prospecting and geological mapping on the Andalusite Peak property. Highl...Read More
TSX.V: TIGOTCMKTS: TIGCF Frankfurt: 8N61 VANCOUVER, Jan. 19, 2018 /CNW/ - Triumph Gold Corp., (TSX-V: TIG) (OTCMKTS: TIGCF) ("Triumph Gold" or the "Company") is pleased to announce that it will be exhibiting at the AME BC Roundup Core Shack on Wednesday, January 24 and...Read More
PRESS RELEASEREGULATED INFORMATION Transparency Information Leuven (BELGIUM) - January 19, 2018, 22:00h CET - TiGenix NV (Euronext Brussels and Nasdaq: TIG) publishes information in accordance with articles 15 and 18 of the Belgian Law of May 2, 2007 regarding the publication o...Read More
Vancouver, British Columbia--(Newsfile Corp. - January 19, 2018) - The following issues have been halted by IIROC: Company: Altai Resources Inc. TSX-V Symbol: ATI Reason: HALT ISSUED IN ERROR FOR ALTAI RESOURCES INC.CORRECT...Read More
TSX.V: TIGOTCMKTS: TIGCF Frankfurt: 8N61 VANCOUVER, Jan. 18, 2018 /CNW/ - Triumph Gold Corp., (TSX-V: TIG) (OTCMKTS: TIGCF) ("Triumph Gold" or the "Company") is pleased to announce the results from 4,685 meters of diamond drilling in sixteen holes targeting the Nucleus Au-Ag...Read More
REGULATED INFORMATIONPRESS RELEASE Transparency notification pursuant to Article 14 of the Law of May 2, 2007 Leuven (Belgium) - January 18, 2018, 22:00h CET - TiGenix NV (Euronext Brussels and Nasdaq: TIG; "TiGenix") publishes today a transparency notification p...Read More
REGULATED INFORMATIONPRESS RELEASE Transparency notifications pursuant to Article 14 of the Law of May 2, 2007 Leuven (Belgium) - January 16, 2018, 22:00h CET - TiGenix NV (Euronext Brussels and Nasdaq: TIG; "TiGenix") announced today that it received transparency not...Read More
PRESS RELEASE TiGenix announces publication in Gastroenterology of 52-week results of the Phase III ADMIRE-CD trial of Cx601 Leuven (BELGIUM) - January 15, 2018, 07:00 CET - TiGenix NV (Euronext Brussels and NASDAQ: TIG), an advanced biopharmaceutical company focused on exploitin...Read More
REGULATED INFORMATIONPRESS RELEASE Transparency notifications pursuant to Article 14 of the Law of May 2, 2007 Leuven (Belgium) - January 12, 2018, 22:00h CET - TiGenix NV (Euronext Brussels and Nasdaq: TIG; "TiGenix") announced today that it received transparency noti...Read More
PRESS RELEASEREGULATED INFORMATION Transparency Information Leuven (BELGIUM) - January 11, 2018, 22:00h CET - TiGenix NV (Euronext Brussels and Nasdaq: TIG) publishes information in accordance with articles 15 and 18 of the Belgian Law of May 2, 2007 regarding t...Read More
TORONTO, Jan. 10, 2018 (GLOBE NEWSWIRE) -- Eurotin Inc. (“Eurotin” or the “Company”) (TSXV:TIN) and Lions Bay Capital Inc. (“Lions Bay”) (TSXV:LBI) are pleased to announce that the Company and certain debtholders, including Lions Bay, have entered into...Read More
REGULATED INFORMATIONPRESS RELEASE Transparency notification pursuant to Article 14 of the Law of May 2, 2007 Leuven (Belgium) - January 3, 2018, 22:00h CEST - TiGenix NV (Euronext Brussels and Nasdaq: TIG; "TiGenix") publishes today a transparency notification pursuan...Read More
Toronto, Ontario--(Newsfile Corp. - December 22, 2017) - Eurotin Inc. ("Eurotin" or the "Company") (TSXV: TIN) is pleased to announce that the Company has completed a private placement of 19,047,619 common shares in the capital of the Company ("Shares") for gross proceeds of $1,000,000 at a price of...Read More
PRESS RELEASE TiGenix confirms strategic focus on Cx601 and its adipose derived stem cell (eASC) platform Leuven (BELGIUM) - December 20, 2017, 7:00h CET - TiGenix NV (Euronext Brussels and NASDAQ: TIG) ("TiGenix" or "the Company"), an advanced biopharmaceutic...Read More
PRESS RELEASE REGULATED INFORMATION INSIDE INFORMATION Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn's disease &#x...Read More
PRESS RELEASE REGULATED INFORMATION INSIDE INFORMATION Mesoblast grants TiGenix an exclusive global patent license to use adipose-derived mesenchymal stem cells in the local treatment of fistulae New York, USA, Melbourne, Australia and Leuven, Belgium, December 15, 2017, 0...Read More
TSX.V: TIGOTCMKTS: TIGCFFrankfurt: 8N61 VANCOUVER, Dec. 11, 2017 /CNW/ - Triumph Gold Corp., (TSX-V: TIG) (OTCMKTS: TIGCF) ("Triumph Gold" or the "Company") is pleased to announce that its trading symbol on the OTCQB Venture Market has changed to TIGCF effective December 7,...Read More
TSX.V: TIGOTCMKTS: TIGCFFrankfurt: 8N61 VANCOUVER, Dec. 11, 2017 /PRNewswire/ - Triumph Gold Corp., (TSX-V: TIG) (OTCMKTS: TIGCF) ("Triumph Gold" or the "Company") is pleased to announce that its trading symbol on the OTCQB Venture Market has changed to TIGCF effective Decem...Read More
TORONTO, ON--(Marketwired - December 08, 2017) - Toachi Mining Inc. ("Toachi" or the "Company") (TSX VENTURE: TIM) is pleased to announce the appointment of Mr. Joseph Fazzini, CPA, CA, CFA as the Company's Chief Financial Officer ("CFO") effective December 5,...Read More
Leuven (Belgium) - November 24, 2017, 22:00h CEST -TiGenix NV (Euronext Brussels and Nasdaq: TIG; "TiGenix") publishes today a transparency notification pursuant to Article 14 of the Belgian Law of May 2, 2007 regarding the publication of major holdings in issuers whose securities a...Read More